$PLNH

Planet 13 Holdings Inc. (PLNH): Results of Operations and Financial Condition

Planet 13 Holdings Inc. (PLNH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_967140.htm EXHIBIT 99.1 ex_967140.htm Exhibit 99.1 Planet 13 Announces Q2 2026 Financial Results ● Q2 2026 Revenue of $22.9 million ● Q2 2026 Net loss of $5.6 million ● Q2 2026 Adjusted EBITDA loss of $0.5 million All figures are reported in United States dollars ($)

Original reporting
Published Aug 12, 2026, 8:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 8:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$PLNH
Neutral
medium confidence
Mentioned
$PLNH
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PLNHNeutralMed
01

Why it matters

Traders can update models for revenue trajectory, gross margin drivers, and ongoing loss profile, while also reassessing merger-related risk given the company’s stated focus on closing.

02

Market read

Fresh quarterly numbers show improving gross margin and reduced Adjusted EBITDA losses, but revenue fell and losses remain, with merger execution as a key narrative driver.

03

What to watch

No Q2 conference call is planned due to the pending merger, which can reduce incremental transparency and increase uncertainty around forward execution and closing timeline.

Relevance 7/10Novelty 7/10Timing: filed after market close, Aug 12, 2026

Background

Planet 13 is a vertically integrated multi-state cannabis operator, and this 8-K includes Q2 2026 financial results plus recent operational updates and the proposed merger with Vireo Growth.

Company-level read

Ticker impact

$PLNHNeutralMedium confidence
Context

Planet 13 filed an 8-K with Q2 2026 results, reporting $22.9M revenue and a $5.6M net loss, plus improved gross margin and Adjusted EBITDA loss.

Expected impact

Near-term trading likely hinges on how investors weigh margin improvement versus revenue compression and merger execution risk.

Evidence & confidence

The filing provides fresh GAAP and non-GAAP figures for the quarter ended June 30, 2026, and reiterates the proposed merger context, which can drive sentiment and positioning.

Market effects

Cannabis operators may face continued price compression, but cost actions and state exits can improve gross margin, influencing sector read-throughs.

Florida revenue growth and California exit are highlighted, suggesting regional demand and regulatory/operational differences matter for earnings power.

Limited direct global relevance; primarily impacts US cannabis microcap sentiment and merger-arbitrage positioning.

Counterpoint

Margin improvement may be partly accounting-driven (inventory reserve reduction) and may not translate into sustainable profitability if price compression persists.

Key entities

  • Planet 13 Holdings Inc.

    OTCQX-listed Planet 13, reporting Q2 2026 revenue, losses, margin improvement, and pending merger context.

  • Vireo Growth Inc.

    Counterparty in Planet 13’s proposed definitive merger agreement referenced in the filing.

Related articles

$BWENMed

Broadwind stock falls 6% as Q2 revenue misses estimates despite strong growth

Broadwind Energy Inc. (NASDAQ:BWEN) shares fell about 6% pre-market after Q2 results missed estimates. The company reported a loss from continuing operations of $0.03 per share versus a $0.01 loss consensus, and revenue of $24.3M versus a $36.29M forecast. Revenue rose 67% year over year to $24.3M, with $35.2M new orders and adjusted EBITDA of $1.6M.

$VITLMed

Vital Infrastructure Property Trust: Vital Infrastructure Reports Second Quarter 2026 Results; Advances Over $150 Million of North American Acquisitions

Vital Infrastructure Property Trust (TSX: VITL.UN) reported Q2 2026 results for the three and six months ended June 30, 2026. Net income fell to $0.3 million from $32.6 million a year earlier, while AFFO rose to $0.11 per unit. The REIT generated about $145 million net cash from selling its European portfolio and, after quarter end, bought a Brooklyn health hub for US$89.9 million and agreed to buy a Canadian outpatient facility for about $26.2 million.

$PAASMed

Pan American Silver Q2 Profit Surges

Pan American Silver Corp. (PAAS) reported a sharp rise in second-quarter net earnings, citing higher metal prices and stronger silver production. The update is expected to affect investor views on profitability and cash generation, with related coverage noting realized silver price and free cash flow figures.

$MDCXMed

Medicus Pharma Ltd: Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Medicus Pharma Ltd. (NASDAQ:MDCX) reported Q2 2026 results for the three and six months ended June 30, 2026, and provided a corporate update. The company said it received FDA “Study May Proceed” authorization for its SkinJect registrational program in Gorlin Syndrome and IRB and FDA feedback for an optimized Teverelix Phase 2 study. Cash was $25.2M at June 30, 2026, with Q2 net loss of $11.7M.